• Ilyang Pharmaceutical major shareholder Jeong Do-eon cut his stake to 1,993,771 shares, or 10.2%, from 12.64%.
• The holding fell by 474,073 shares on Sept. 21 via a gift.
• Jeong remains a 10%+ shareholder following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ilyang Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923000527), on September 23, 2026, and is solely responsible for the information contained therein.